Clearance Summary
ZOLL PROPAQ XM received FDA 510(k) clearance under submission number K121367, sponsored by ZOLL Medical Corporation. The device was reviewed via the Traditional premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2012-06-21.
- Submission: K121367
- Applicant / Sponsor: ZOLL Medical Corporation
- Clearance pathway: Traditional
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.1025
- Decision date: 2012-06-21
Classification & Regulation
This clearance is catalogued under FDA product code MHX and 21 CFR 870.1025, within the Cardiovascular review panel as a Class II device.